Inhalant abuse with intoxication, uncomplicated
ICD-10 F18.120 is a billable code used to indicate a diagnosis of inhalant abuse with intoxication, uncomplicated.
Inhalant abuse refers to the intentional inhalation of volatile substances to achieve psychoactive effects. This behavior can lead to a range of health issues, including neurological damage, respiratory problems, and cardiovascular complications. The diagnosis of uncomplicated inhalant intoxication indicates that the individual is experiencing the immediate effects of inhalant use without any co-occurring medical complications or severe withdrawal symptoms. Symptoms of intoxication may include euphoria, dizziness, hallucinations, and impaired motor function. Clinicians must assess the patient's history of inhalant use, the frequency and quantity of use, and any associated psychosocial factors. Treatment typically involves supportive care, counseling, and referral to substance use disorder treatment programs. It is crucial to monitor the patient for potential complications, as inhalant abuse can lead to long-term cognitive deficits and other serious health issues. The uncomplicated nature of this diagnosis suggests that the patient does not exhibit severe withdrawal symptoms or complications that would necessitate more intensive medical intervention.
Thorough documentation of substance use history, including frequency and quantity of inhalant use, and psychosocial factors.
Patients presenting with acute intoxication symptoms, seeking help for substance use, or experiencing withdrawal symptoms.
Consideration of co-occurring mental health disorders and the need for integrated treatment approaches.
Detailed mental health assessments, including evaluation of cognitive function and mood disorders.
Patients with a history of inhalant use presenting with mood disturbances or cognitive impairments.
Assessment of the impact of inhalant use on mental health and the need for psychiatric intervention.
Used in conjunction with inhalant abuse treatment for patients with co-occurring tobacco use.
Document the counseling session, including patient engagement and follow-up plans.
Consider the impact of tobacco use on overall treatment outcomes.
Common symptoms include euphoria, dizziness, hallucinations, slurred speech, and impaired motor function. In severe cases, respiratory distress and loss of consciousness may occur.
